CAM
IDXX icon

Cresset Asset Management’s Idexx Laboratories IDXX Stock Holding History

Cresset Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
2,497
-221
-8% -$124K ﹤0.01% 801
2026
Q1 		$1.53M Buy
2,718
+346
+15% +$222K 0.01% 632
2025
Q4 		$1.6M Sell
2,372
-252
-10% -$172K 0.01% 631
2025
Q3 		$1.68M Buy
2,624
+492
+23% +$299K 0.01% 592
2025
Q2 		$1.14M Sell
2,132
-484
-19% -$231K 0.01% 645
2025
Q1 		$1.1M Buy
2,616
+259
+11% +$112K 0.01% 742
2024
Q4 		$974K Sell
2,357
-4,838
-67% -$2.12M ﹤0.01% 810
2024
Q3 		$3.64M Buy
7,195
+582
+9% +$283K 0.01% 544
2024
Q2 		$3.22M Buy
6,613
+383
+6% +$192K 0.01% 544
2024
Q1 		$3.36M Buy
6,230
+251
+4% +$137K 0.02% 463
2023
Q4 		$3.32M Buy
5,979
+948
+19% +$445K 0.02% 417
2023
Q3 		$2.2M Buy
5,031
+131
+3% +$65.3K 0.01% 520
2023
Q2 		$2.46M Buy
4,900
+3,031
+162% +$1.45M ﹤0.01% 585
2023
Q1 		$935K Sell
1,869
-122
-6% -$58.4K 0.02% 355
2022
Q4 		$812K Sell
1,991
-11
-0.5% -$4.27K 0.01% 344
2022
Q3 		$652K Buy
2,002
+437
+28% +$161K 0.01% 448
2022
Q2 		$548K Sell
1,565
-1,359
-46% -$554K 0.01% 530
2022
Q1 		$1.6M Sell
2,924
-511
-15% -$269K 0.02% 291
2021
Q4 		$2.26M Sell
3,435
-12
-0.3% -$7.53K 0.02% 273
2021
Q3 		$2.14M Buy
3,447
+170
+5% +$114K 0.03% 219
2021
Q2 		$2.07M Sell
3,277
-141
-4% -$77.9K 0.03% 200
2021
Q1 		$1.67M Buy
3,418
+1,292
+61% +$647K 0.03% 195
2020
Q4 		$1.06M Buy
2,126
+144
+7% +$64.4K 0.02% 237
2020
Q3 		$779K Buy
1,982
+441
+29% +$163K 0.01% 275
2020
Q2 		$509K Sell
1,541
-42
-3% -$12.2K 0.01% 337
2020
Q1 		$383K Buy
+1,583
New +$413K 0.01% 339
2019
Q2 		– Sell
-283
Closed -$63K – 1025
2019
Q1 		$63K Buy
283
+162
+134% +$33.4K ﹤0.01% 714
2018
Q4 		$23K Buy
+121
New +$24.8K ﹤0.01% 677

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cresset Asset Management's IDXX Position: Q2 2026 in Review

Cresset Asset Management reduced its Idexx Laboratories (IDXX) stake by 8.1% in Q2 2026, selling an estimated $124K and leaving 2,497 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Cresset Asset Management first reported a position in IDXX in Q4 2018 and has held it in 28 quarters since. The position peaked at $3.64M in Q3 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cresset Asset Management held 2,497 shares of Idexx Laboratories worth $1.31M as of Q2 2026.
  • Cresset Asset Management sold 221 Idexx Laboratories shares in Q2 2026, an estimated $124K.
  • Idexx Laboratories made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #801 holding.
  • Cresset Asset Management first reported a position in Idexx Laboratories in Q4 2018 and has held it in 28 quarters since.
  • Cresset Asset Management's Idexx Laboratories position peaked at $3.64M in Q3 2024.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.